La heredabilidad de las influencias farmacogenéticas hace pensar en la necesidad de recolectar la información sobre la medicación como parte de la historia de salud familiar, antes de tomar decisiones terapéuticas. El tema es propuesto en Haga SB, Orlando LA. Expanding Family Health History to Include Family Medication History. J. Pers. Med. 2023;13(3):410.
Filed under Farmacogenómica by on . Comment. 
– Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework. JMIR Med Educ 2023;9:e43656.
– Advancing Precision Medicine in Medical Education: Integrated, Precise and Data-driven Smart Solutions. Appl. Res. 2023; https://doi.org/10.1002/appl.202200131
– Awareness, understanding, and interest in personalized medicine: A cross-sectional survey study of college students. PLoS ONE, 2023;18(1):e0280832.
Filed under Medicina personalizada by on . Comment.
La propuesta de “de-extinguir” al dodo, ave no voladora desaparecida en el siglo XVII por la depredación humana, implica retos tecnológicos y ecológicos. Estas y otras consideraciones son abordadas en Callaway E. What it would take to bring back the dodo. Nature, 2023; https://doi.org/10.1038/d41586-023-00379-5.
Filed under Otros Proyectos Genoma by on . Comment.
Con el seguimiento a dos muestras del proyecto All of Us se determinó que las lecturas largas en la secuenciación del genoma producen los resultados más precisos. Otros resultados son comentados en Mahmoud M, Huang Y, Garimella K, Audano PA, Wan W, Prasad N, Handsaker RE, et al. Utility of long-read sequencing for All of Us. BioRXiv, 2023.
Filed under Bioinformática, Genómica by on . Comment.
– Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer
– Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing
– The Pathogenic Diagnosis in Pediatric Diabetology: Next Generation Sequencing and Precision Therapy
– Systematic assessment of prognostic molecular features across cancers
– Landscape of pathogenic mutations in premature ovarian insufficiency
– Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group
– Exome/Genome Sequencing in Undiagnosed Syndromes
– Precision Medicine and the future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review
Filed under Cáncer, Cardiopatías, Diagnóstico by on . Comment.
